These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4741040)

  • 21. Evidence for the involvement of central serotonergic mechanisms in cholinergic tremor induced by tacrine in Balb/c mice.
    Mehta H; Haobam R; Usha R; Mohanakumar KP
    Behav Brain Res; 2005 Sep; 163(2):227-36. PubMed ID: 15990178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental data suggesting an adrenergic mechanism in the production of parkinsonian symptoms.
    Silvestrini B; Lisciani R
    Curr Ther Res Clin Exp; 1976 Nov; 20(5):716-24. PubMed ID: 136334
    [No Abstract]   [Full Text] [Related]  

  • 23. The influence of cholinolytics on clonidine action.
    Maj J; Baran L; Sowińska H; Zieliński M
    Pol J Pharmacol Pharm; 1975; 27(1):17-26. PubMed ID: 1118365
    [No Abstract]   [Full Text] [Related]  

  • 24. Experiments on antagonism of ketamine anesthesia in cats given adrenergic, serotonergic, and cholinergic stimulants alone and in combination.
    Hatch RC; Ruch T
    Am J Vet Res; 1974 Jan; 35(1):35-9. PubMed ID: 4809596
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of tremorine and oxotremorine on aerobic glycolysis in rat brain.
    Yoshida T; Igić R
    Neuropharmacology; 1972 Nov; 11(6):827-30. PubMed ID: 4638182
    [No Abstract]   [Full Text] [Related]  

  • 26. Nicotinic acetylcholine receptor alpha5 subunits modulate oxotremorine-induced salivation and tremor.
    Wang N; Orr-Urtreger A; Chapman J; Rabinowitz R; Korczyn AD
    J Neurol Sci; 2004 Jul; 222(1-2):87-91. PubMed ID: 15240201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meperidine does not block the cholinergic effects of oxotremorine.
    Leander JD
    Pharmacol Biochem Behav; 1979 Jun; 10(6):941-2. PubMed ID: 482317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relation between the type of higher nervous activity, some biochemical parameters and reactivity to drugs.
    Benesová O; Benes V
    Act Nerv Super (Praha); 1968 May; 10(2):223-31. PubMed ID: 4882558
    [No Abstract]   [Full Text] [Related]  

  • 29. Potentiation and inhbition of some central actions of L(-)-dopa by decarboxylase inhibitors.
    Lotti VJ; Porter CC
    J Pharmacol Exp Ther; 1970 Apr; 172(2):406-15. PubMed ID: 5441162
    [No Abstract]   [Full Text] [Related]  

  • 30. Oxotremorine behavioural effects as a screening test in mice.
    Frances H; Chermat R; Simon P
    Prog Neuropsychopharmacol; 1980; 4(3):241-6. PubMed ID: 6107942
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacodynamic evaluation of selective antimuscarinic properties of pirenzepine in the rat.
    Del Soldato P; Pagani F
    Pharmacol Res Commun; 1982 Mar; 14(3):279-87. PubMed ID: 6896580
    [No Abstract]   [Full Text] [Related]  

  • 32. Device for quantitating tremor activity in mice: antitremor activity of atropine versus soman- and oxotremorine-induced tremors.
    Clement JG; Dyck WR
    J Pharmacol Methods; 1989 Aug; 22(1):25-36. PubMed ID: 2770314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amygdala beta-noradrenergic influences on memory storage involve cholinergic activation.
    Introini-Collison IB; Dalmaz C; McGaugh JL
    Neurobiol Learn Mem; 1996 Jan; 65(1):57-64. PubMed ID: 8673407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of low dose methylmercury administration during the postnatal brain growth spurt in rats.
    Coluccia A; Borracci P; Giustino A; Sakamoto M; Carratù MR
    Neurotoxicol Teratol; 2007; 29(2):282-7. PubMed ID: 17141469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the central effects of atropine in the dog.
    Albanus L; Aquilonius SM; Sundwall A; Winbladh B
    Acta Pharmacol Toxicol (Copenh); 1967; 25():Suppl 4:73. PubMed ID: 5630964
    [No Abstract]   [Full Text] [Related]  

  • 36. Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist.
    Hahn RA; Wardell JR; Sarau HM; Ridley PT
    J Pharmacol Exp Ther; 1982 Nov; 223(2):305-13. PubMed ID: 6127401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison of certain central effects of atropine, scopolamine and their quaternary ammonium derivatives in animals].
    Malatray J; Simon P
    Therapie; 1972; 27(1):153-66. PubMed ID: 5017551
    [No Abstract]   [Full Text] [Related]  

  • 38. Behavioural and vegetative effects of dibutyryl cyclic AMP on conscious dogs.
    Ono H; Taira N; Hashimoto K
    Neuropharmacology; 1976 Sep; 15(9):571-5. PubMed ID: 185542
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacological study of oral CDP-choline. Interaction with oxotremorine on the parasympathetic system.
    Tornos ME; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1026-9. PubMed ID: 6684457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maternal exposure to diphenhydramine during the fetal period in rats: effects on physical and neurobehavioral development and on neurochemical parameters.
    Moraes AP; Schwarz A; Spinosa HS; Florio JC; Bernardi MM
    Neurotoxicol Teratol; 2004; 26(5):681-92. PubMed ID: 15315817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.